Retraction notice to "Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib" [Life Sci. 259 (2020) 118150]

Affiliations

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
² Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
⁴ Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
⁵ Department of Oncology, Cross Cancer Institute, The University of Alberta, Edmonton, Alberta, Canada.
⁶ Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
⁷ Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
⁸ Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia 5714783734, Iran.
⁹ Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
¹⁰ Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
¹¹ Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.
¹² Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Retraction of Publication

Shahin Hallaj et al. Life Sci. 2024.

. 2024 Aug 1:350:122773.

doi: 10.1016/j.lfs.2024.122773. Epub 2024 Jun 6.

¹ Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
² Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
³ Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
⁴ Department of Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
⁵ Department of Oncology, Cross Cancer Institute, The University of Alberta, Edmonton, Alberta, Canada.
⁶ Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
⁷ Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
⁸ Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia 5714783734, Iran.
⁹ Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
¹⁰ Cellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.
¹¹ Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.
¹² Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

No abstract available

Retraction of

Inhibition of CD73 using folate targeted nanoparticles carrying anti-CD73 siRNA potentiates anticancer efficacy of Dinaciclib.
Hallaj S, Heydarzadeh Asl S, Alian F, Farshid S, Eshaghi FS, Namdar A, Atyabi F, Masjedi A, Hallaj T, Ghorbani A, Ghalamfarsa G, Sojoodi M, Jadidi-Niaragh F. Hallaj S, et al. Life Sci. 2020 Oct 15;259:118150. doi: 10.1016/j.lfs.2020.118150. Epub 2020 Jul 26. Life Sci. 2020. Retraction in: Life Sci. 2024 Aug 1;350:122773. doi: 10.1016/j.lfs.2024.122773. PMID: 32726663 Retracted.